Vivos Inc Revenue Growth Rates (RDGL), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Vivos Inc  (RDGL)
 

RDGL's Revenue Growth by Quarter and Year

Vivos Inc's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RDGL Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June -
1st Quarter March 0.04
FY 0.04

RDGLs Annual Revenue
Vivos Inc's Revenue in the fiscal year 2025 $ 0.07 millions
Vivos Inc's Revenue in the fiscal year 2024 $ 0.03 millions
Vivos Inc's Revenue in the fiscal year 2023 $ 0.02 millions
Vivos Inc's Revenue in the fiscal year 2022 $ 0.04 millions
Vivos Inc's Revenue in the fiscal year 2021 $ 0.01 millions




RDGL Revenue first quarter 2026 Y/Y Growth Comment
Vivos Inc achieved in the first quarter 2026, above Company average Revenue growth of 20.23% year on year, to $ 0.04 millions.

Looking into first quarter 2026 results within Medical Equipment & Supplies industry 105 other companies have achieved higher Revenue growth. While Vivos Inc' s Revenue rise of 20.23% ranks overall at the positon no. 2035 in the first quarter 2026.


RDGL Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - - - 0 %
3rd Quarter September - - 0 % 0 %
2nd Quarter June - 100 % 0 % 0 %
1st Quarter March 20.23 % - - -
FY   - 250 % -50 % -

Financial Statements
Vivos Inc's first quarter 2026 Revenue $ 0.04 millions RDGL's Income Statement
Vivos Inc's first quarter 2025 Revenue $ 0.03 millions Quarterly RDGL's Income Statement


RDGL Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - - - 0 %
3rd Quarter September - - 0 % 0 %
2nd Quarter June - -33.33 % - 0 %
1st Quarter March 80.34 % - - 0 %
FY (Year on Year)   - 250 % -50 % -


Back to RDGL Growth rate Comparisons >> Back to RDGL Growth rate Comparisons >>


Revenue first quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #106
Healthcare Sector #297
Overall #2035

Revenue Y/Y Growth Statistics
High Average Low
62.74 % 19.01 % -18.76 %
(Mar 31 2026)   (Jun 30 2023)
Revenue first quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #106
Healthcare Sector #297
Overall #2035
Revenue Y/Y Growth Statistics
High Average Low
62.74 % 19.01 % -18.76 %
(Mar 31 2026)   (Jun 30 2023)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Vivos Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
1217.3 % 81.13 % -100 %
(Dec 31 2025)  


RDGL's I. Quarter Q/Q Revenue Comment
Vivos Inc achieved in the I. Quarter 2026 below company average Revenue jump of 80.34% quarter on quarter, to $ 0.04 millions.

I. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the % in the I. Quarter a year ago.

Within Medical Equipment & Supplies industry 7 other companies have achieved higher Revenue quarter on quarter growth. While Vivos Inc's Revenue growth quarter on quarter, overall rank is 129.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #8
Healthcare Sector #42
Overall #129
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #8
Healthcare Sector #42
Overall #129
Revenue Q/Q Growth Statistics
High Average Low
1217.3 % 81.13 % -100 %
(Dec 31 2025)  


RDGL's I. Quarter Q/Q Revenue Comment
Vivos Inc achieved in the I. Quarter 2026 below company average Revenue jump of 80.34% quarter on quarter, to $ 0.04 millions.

I. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the % in the I. Quarter a year ago.

Within Medical Equipment & Supplies industry 7 other companies have achieved higher Revenue quarter on quarter growth. While Vivos Inc's Revenue growth quarter on quarter, overall rank is 129.


Vivos Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)		 12 Months Ending
(Mar 31 2025)
Cumulative Revenue 12 Months Ending $ 0.08 $ 0.07 $ 0.05 $ 0.05 $ 0.05
Y / Y Revenue Growth (TTM) 62.74 % - - - -
Year on Year Revenue Growth Overall Ranking # 212 # 0 # 0 # 0 # 0
Seqeuential Revenue Change (TTM) 13.63 % 48.26 % -6.34 % 3.14 % -
Seq. Revenue Growth (TTM) Overall Ranking # 2035 # 1871 # 1917 # 1703 # 0


Cumulative Revenue growth Comment
With 62.74% annual Revenue growth, Vivos Inc would report a record annual Revenue growth if the fiscal year would end on Mar 31 2026.

In the Healthcare sector 65 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 212.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 106
Healthcare Sector # 66
Overall # 212

Revenue TTM Y/Y Growth Statistics
High Average Low
62.74 %
 19.01 %
-18.76 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 106
Sector # 297
S&P 500 # 2035
Cumulative Revenue growth Comment
With 62.74% annual Revenue growth, Vivos Inc would report a record annual Revenue growth if the fiscal year would end on Mar 31 2026.

In the Healthcare sector 65 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 212.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 106
Healthcare Sector # 66
Overall # 212

Revenue TTM Y/Y Growth Statistics
High Average Low
62.74 %
19.01 %
-18.76 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 106
Sector # 297
S&P 500 # 2035




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
RDGL's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Mar 31 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2026
Adaptive Biotechnologies Corporation35.14%$ 35.145 millions
Brightspring Health Services Inc 35.10%$ 35.104 millions
Vivos Inc34.84%$ 34.844 millions
Neuroone Medical Technologies Corp34.29%$ 34.290 millions
Insulet Corporation33.87%$ 33.866 millions
Sonida Senior Living Inc 33.41%$ 33.407 millions
Zomedica Corp 32.42%$ 32.418 millions
Krystal Biotech Inc 31.95%$ 31.949 millions
Northwest Biotherapeutics Inc31.73%$ 31.733 millions
Geron Corporation30.89%$ 30.892 millions
Ceribell Inc 30.56%$ 30.564 millions
Scientific Industries Inc 30.22%$ 30.224 millions
Vericel Corporation30.09%$ 30.090 millions
Kura Oncology Inc 29.47%$ 29.466 millions
Butterfly Network Inc 28.97%$ 28.974 millions
Alkermes Plc 28.19%$ 28.189 millions
Grail Inc 28.11%$ 28.106 millions
Delcath Systems Inc 28.08%$ 28.085 millions
Viemed Healthcare Inc 27.54%$ 27.541 millions
Ardelyx inc 27.47%$ 27.470 millions
Lightwave Logic Inc 27.27%$ 27.272 millions
Lipocine Inc 27.20%$ 27.202 millions
Globus Medical Inc 27.04%$ 27.040 millions
Axogen inc 26.56%$ 26.559 millions
Medpace Holdings Inc 26.50%$ 26.502 millions
Nuwellis Inc 26.21%$ 26.208 millions
Elite Pharmaceuticals Inc 26.17%$ 26.174 millions
Irhythm Holdings Inc 26.00%$ 26.001 millions
Privia Health Group Inc 25.78%$ 25.776 millions
Edap Tms Sa24.85%$ 24.848 millions


About Vivos Inc Revenue Growth Rates (RDGL), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Vivos Inc (CIK 1449349).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001493152-26-037380
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Vivos Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.